INTRODUCTIONMolluscum contagiosum is a highly contagious, benign neoplastic, infectious dermatologic disease.1 It is commonly seen in children, sexually active young adults, and immunosuppressed patients.2,3 MC is a member of the…
Read More
INTRODUCTIONMany of the oral small molecules (OSM) and biologic immune response modifier drugs share indications for use, such as in psoriasis and rheumatoid arthritis. The OSMs azathioprine, cyclosporine, methotrexate, and…
Read More
Introduction Seborrheic dermatitis (SD) is a chronic, relapsing, inflammatory dermatosis with ambiguous pathophysiology of overcolonization of Malassezia combined with predisposing factors including sebocyte activity, impaired immunity with diminished T-cell responses…
Read More
INTRODUCTIONVitiligo is a complex multifactorial disorder of depigmentation affecting 0.5 to 2% of the world's population without specific gender or racial prevalence.1 Though no treatments are FDA approved to repigment…
Read More
INTRODUCTIONHidradenitis suppurativa (HS) is an inflammatory skin disease characterized by deep suppurative nodules and abscesses generally in areas containing apocrine glands. Previously thought to be caused by dysregulated processes affecting…
Read More
INTRODUCTIONTofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular…
Read More
INTRODUCTIONCervical region is strongly impacted by the aging process that may progress with skin atrophy, accumulation of submental fat, wrinkles, loss of contour, and sagging skin. Among so many changes…
Read More
INTRODUCTIONPretibial myxedema (PTM) is a rare manifestation of Graves’ disease and less commonly Hashimoto’s thyroiditis. The progression of Graves’ disease usually begins with thyroid dysfunction, followed by thyroid-associated ophthalmopathy (TAO)…
Read More
INTRODUCTIONTumor necrosis factor (TNF) antagonists have revolutionized management for various autoimmune and inflammatory conditions, including rheumatoid arthritis (RA), inflammatory bowel disease, hidradenitis suppurativa, psoriatic arthritis, and plaque psoriasis. However, adverse…
Read More
INTRODUCTIONEpoprostenol (Flolan) is a last-resort intravenous (IV) medication for the treatment of severe pulmonary arterial hypertension (PAH). Cutaneous adverse events of Flolan are well-known by pulmonologists, though lacking in dermatologic…
Read More
INTRODUCTIONTelehealth became widely implemented in pediatric dermatology practices as a result of the COVID-19 pandemic. However, patient preferences for using telehealth for specific skin conditions remain in question. Here, we…
Read More
INTRODUCTIONAlopecia areata (AA) is a nonscarring alopecia, characterized by patchy hair loss affecting the scalp, face, and body, with a smaller subset of patients progressing to alopecia totalis (AT) or…
Read More
